ADPT · Adaptive Biotechnologies Corp
United States · RS rating 91 · As of 2026-10-14
| Price | 25.62 USD |
|---|---|
| 1-day change | +1.3% |
| RS rating (overall / 1M / 3M / 12M) | 91 / 41 / 89 / 92 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 46 / 46 / 46 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -250.0% |
| Sales growth Q/Q | -23.7% |
| Distance from 52-week high | +14.1% |
| Market cap (USD) | $2.1B |